Welcome to another captivating episode of Delta, the podcast where we delve deep into the world of science, technology, and innovation in Health Care. In this episode, your host Roupen sits down with Dr. Worthley, one of the corresponding authors of a groundbreaking paper in the realm of synthetic biology and disease detection. They discuss how engineered bacteria can detect colon cancer early and how this can revolutionize the colon cancer screening world.🔬 Episode Highlights: 3:26 What is bacterial engineering? 7:27 What is horizontal gene transfer? 13:25 What is CRISPR 26:30 Step-by-step breakdown of the technology 36:00 Current colon cancer screening methods 43:56 Advantages of cell based screening for colon cancer 55:00 Ethical considerationsDr. Worthley contact: dan@colonoscopyclinic.con.au CATCH Technology website: https://www.catch.contact/ Read the paper: https://www.science.org/doi/10.1126/science.adf3974
Delta: HealthTech Innovators